Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Conrad

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
Research Square|February 20, 2025
Performance of Molecular Inversion Probe DR23K and Paragon MAD4HatTeR Amplicon Sequencing Panels for Detection of Plasmodium falciparum Mutations Associated with Antimalarial Drug ResistanceThomas Katairo, Victor Asua, Bienvenu Nsengimaana, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2022
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome InhibitorsShreeya Garg, Oriana Kreutzfeld, Sevil Chelebieva, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2024
The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh <i>Plasmodium falciparum</i> isolatesMartin Okitwi, Douglas A Shoue, Lisa A Checkley, et al.
Nature Medicine|May 6, 2024
Urgent action is needed to confront artemisinin partial resistance in African malaria parasitesDeus S Ishengoma, Roly Gosling, Rosario Martinez-Vega, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Significant variations in tolerance to clothianidin and pirimiphos-methyl in <i>Anopheles gambiae</i> and <i>Anopheles funestus</i> populations during a dramatic malaria resurgence despite sustained indoor residual spraying in UgandaAmbrose Oruni, Emmanuel Arinaitwe, James Adiga, et al.
The Lancet. Infectious Diseases|August 22, 2025
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trialMoses R Kamya, Joaniter I Nankabirwa, Chris Ebong, et al.
Parasites & Vectors|June 23, 2025
Significant variations in tolerance to clothianidin and pirimiphos-methyl in Anopheles gambiae and Anopheles funestus populations during a dramatic malaria resurgence despite sustained indoor residual spraying in UgandaAmbrose Oruni, Emmanuel Arinaitwe, James Adiga, et al.
The Journal of Infectious Diseases|June 14, 2024
Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in UgandaStephen Tukwasibwe, Shreeya Garg, Thomas Katairo, et al.
Malaria Journal|June 12, 2025
Performance of molecular inversion probe DR23K and Paragon MAD<sup>4</sup>HatTeR Amplicon sequencing panels for detection of Plasmodium falciparum mutations associated with antimalarial drug resistanceThomas Katairo, Victor Asua, Bienvenu Nsengimaana, et al.
Malaria Journal|May 1, 2025
Field evaluation of the Bioline Malaria Ag P.f/Pan rapid diagnostic test: causes of microscopy discordance and performance in UgandaKisakye Diana Kabbale, Bienvenu Nsengimaana, Francis D Semakuba, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Research Square|February 20, 2025
Performance of Molecular Inversion Probe DR23K and Paragon MAD4HatTeR Amplicon Sequencing Panels for Detection of Plasmodium falciparum Mutations Associated with Antimalarial Drug ResistanceThomas Katairo, Victor Asua, Bienvenu Nsengimaana, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2022
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome InhibitorsShreeya Garg, Oriana Kreutzfeld, Sevil Chelebieva, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2024
The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh <i>Plasmodium falciparum</i> isolatesMartin Okitwi, Douglas A Shoue, Lisa A Checkley, et al.
Nature Medicine|May 6, 2024
Urgent action is needed to confront artemisinin partial resistance in African malaria parasitesDeus S Ishengoma, Roly Gosling, Rosario Martinez-Vega, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Significant variations in tolerance to clothianidin and pirimiphos-methyl in <i>Anopheles gambiae</i> and <i>Anopheles funestus</i> populations during a dramatic malaria resurgence despite sustained indoor residual spraying in UgandaAmbrose Oruni, Emmanuel Arinaitwe, James Adiga, et al.
The Lancet. Infectious Diseases|August 22, 2025
Efficacies of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trialMoses R Kamya, Joaniter I Nankabirwa, Chris Ebong, et al.
Parasites & Vectors|June 23, 2025
Significant variations in tolerance to clothianidin and pirimiphos-methyl in Anopheles gambiae and Anopheles funestus populations during a dramatic malaria resurgence despite sustained indoor residual spraying in UgandaAmbrose Oruni, Emmanuel Arinaitwe, James Adiga, et al.
The Journal of Infectious Diseases|June 14, 2024
Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in UgandaStephen Tukwasibwe, Shreeya Garg, Thomas Katairo, et al.
Malaria Journal|June 12, 2025
Performance of molecular inversion probe DR23K and Paragon MAD<sup>4</sup>HatTeR Amplicon sequencing panels for detection of Plasmodium falciparum mutations associated with antimalarial drug resistanceThomas Katairo, Victor Asua, Bienvenu Nsengimaana, et al.
Malaria Journal|May 1, 2025
Field evaluation of the Bioline Malaria Ag P.f/Pan rapid diagnostic test: causes of microscopy discordance and performance in UgandaKisakye Diana Kabbale, Bienvenu Nsengimaana, Francis D Semakuba, et al.
Pageof 26